Search clinical trials for: TAK-071 Placebo
Total 59199 results
-
TakedaMichael J. Fox Foundation for Parkinson's ResearchCompletedParkinson Disease | Healthy ParticipantsUnited States
-
TakedaWithdrawn
-
Millennium Pharmaceuticals, Inc.CompletedSystemic Lupus Erythematosus | Lupus Erythematosus, SystemicUnited States
-
Neurocrine BiosciencesTakedaCompletedSchizophrenia | Healthy VolunteersUnited States
-
TakedaCompletedMyasthenia GravisUnited States, Spain, Canada, Serbia, Italy, Poland
-
Samsung Bioepis Co., Ltd.Completed
-
TakedaActive, not recruitingPrimary Immune ThrombocytopeniaSpain, United States, Croatia, Italy, China, Germany, Bulgaria, Greece, Slovenia, Japan, Ukraine
-
TakedaCompletedAutoimmune DiseaseUnited Kingdom
-
TakedaTerminatedAlzheimer Disease | Healthy VolunteersUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid TumorsUnited States
-
Neurocrine BiosciencesCompletedAnhedonia | Major Depressive DisorderUnited States, Puerto Rico
-
TakedaActive, not recruitingGlomerulonephritis | Kidney DiseaseTaiwan, Australia, Hungary, Spain, United Kingdom, United States, China, Korea, Republic of, Italy, Japan, Singapore
-
TakedaRecruitingAlpha1-Antitrypsin DeficiencyUnited States, Poland
-
TakedaWithdrawn
-
TakedaTerminatedAttention-Deficit/Hyperactivity DisorderUnited States
-
TakedaTerminatedCardiovascular Disease | Type 2 DiabetesUnited States, France, Poland, Ukraine, Germany, Hong Kong, Taiwan, Argentina, Israel, Mexico, Bulgaria, Malaysia, Romania, Canada, Korea, Republic of, New Zealand, Peru, Estonia, Philippines, Russian Federation, Czech Republic, H... and more
-
Millennium Pharmaceuticals, Inc.CompletedA Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic HypersomniaIdiopathic HypersomniaUnited States, Japan
-
TakedaWithdrawnHealthy VolunteersUnited States
-
Neurocrine BiosciencesTakedaCompletedFriedreich AtaxiaUnited States
-
TakedaCompletedJapanese Healthy Adult Male ParticipantsJapan
-
TakedaCompletedHealthy ParticipantsUnited States
-
TakedaCompletedHealthy ParticipantsUnited States
-
TakedaCompleted
-
TakedaTakeda Development Center Americas, Inc.CompletedPostoperative Gastrointestinal DysfunctionUnited States, Germany
-
Neurocrine BiosciencesTakedaCompletedDepressive DisorderUnited Kingdom
-
Millennium Pharmaceuticals, Inc.Completed
-
TakedaCompleted
-
TakedaTerminatedType 2 Diabetes MellitusTaiwan, China, Korea, Republic of, New Zealand, Australia
-
TakedaCompletedGastroesophageal Reflux Disease (GERD) | Erosive Esophagitis(EE)United Kingdom
-
TakedaTakeda Development Center Americas, Inc.TerminatedCrohn DiseaseUnited States, Germany, Austria, France, United Kingdom
-
Millennium Pharmaceuticals, Inc.Terminated
-
Neurocrine BiosciencesTakedaTerminatedSchizophrenia, Cerebellar AtaxiaUnited Kingdom
-
TakedaTakeda Development Center Americas, Inc.RecruitingAlpha1-Antitrypsin DeficiencyUnited States, Belgium, Switzerland, Canada, Australia, Germany, United Kingdom, Austria, France, Spain, Portugal, Italy, Poland
-
TakedaTerminated
-
National Cancer Institute (NCI)CompletedHead and Neck Cancer | Head and Neck NeoplasmsUnited States
-
Patagonia Pharmaceuticals, LLCCompletedCongenital IchthyosisUnited States
-
Henan Cancer HospitalNot yet recruitingPerioperative Period | Malignant Tumor of Bone
-
Henan Cancer HospitalNot yet recruitingApplication of Douyin in Patients With Bone and Soft Tissue Malignant Tumors During PerichemotherapyChemotherapy | Malignant Tumor
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
Neurocrine BiosciencesTakedaCompleted
-
TakedaActive, not recruitingNarcolepsy Type 2Spain, United States, Japan, Italy, France, Germany, Australia, Netherlands, Finland, Norway, Sweden, Switzerland
-
TakedaCompletedHealthy Participants and Patients With NarcolepsyJapan
-
TakedaCompleted
-
TakedaOvid Therapeutics Inc.CompletedDevelopmental and/or Epileptic EncephalopathiesUnited States
-
TakedaCompletedDiabetic NeuropathiesUnited States, Canada
-
TakedaCompletedAscending Single Dose Study